October 03, 2013
The U.S. Judicial Panel on Multidistrict Litigation on Wednesday selected Rhode Island for the centralization of six nationwide class actions accusing pharmaceutical company Warner Chilcott PLC of illegally muscling generic competitors for its oral contraceptive Loestrin out of the market.
April 08, 2013
Warner Chilcott PLC was hit with a class action on Friday alleging the drugmaker violated U.S. antitrust laws when it agreed to settle "sham" patent infringement litigation against Lupin Pharmaceuticals Inc. and Watson Pharmaceuticals Inc. that delayed entry of generic versions of oral contraceptive Loestrin.